Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 12.51.
Forward PE Ratio (12.51) = Close Price ($89.57) / Consensus Forward EPS ($7.16)
FORWARD PE RATIO
12.51
SECTOR MEDIAN · HEALTHCARE
19.91
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
-37.18%
vs the sector median at left
Solventum Corporation
Market Cap
$15.51B
Forward PE Ratio
12.51
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Solventum Corporation (SOLV) | $15.51B | 12.51 |
| The Cooper Companies, Inc. (COO)vs › | $14.87B | 16.46 |
| Charles River Laboratories International, Inc. (CRL)vs › | $14.22B | 26.08 |
| Revvity, Inc. (RVTY)vs › | $13.92B | 23.29 |
| Medpace Holdings, Inc. (MEDP)vs › | $17.33B | 35.27 |
| Baxter International Inc. (BAX)vs › | $13.62B | 12.83 |
| Exelixis, Inc. (EXEL)vs › | $13.59B | 18.14 |
| Tempus AI, Inc. (TEM)vs › | $12.74B | N/A |
| Viatris Inc. (VTRS)vs › | $19.01B | 6.53 |
| Align Technology, Inc. (ALGN)vs › | $11.64B | 14.40 |
Trailing P/E
10.9
reported TTM EPS
Forward P/E
12.5
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $7.16 implies -12.6% EPS decline vs the reported trailing $8.19.
At today's $89.57 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $7.16 | $6.58 – $7.58 | 9 | 12.5x |
| 2027-12-31 | $7.30 | $6.59 – $7.65 | 10 | 12.3x |
| 2028-12-31 | $8.09 | $4.14 – $10.47 | 6 | 11.1x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute